Advertisement

Injectable Soft Tissues with Fibroblasts and Mesenchymal Cells

  • Neide Kalil GasparEmail author
  • Patricia Shu Kurizky
Living reference work entry

Latest version View entry history

Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)

Abstract

The use of autologous cells expanded from dermis or mesenchymal cells of adipose tissue has been studied, and it seems to be a promising technique in cosmetic dermatology. This process consists in the implant of expanded cells obtained either by excision of skin graft from occipital area or taken by liposuction from adipose abdominal tissue. Even skin flaps from plastic surgery can be used. These materials are sent to laboratory in appropriate growth medium and expanded after submitted to microbiological control. After about 45 days, it is possible to provide ten syringes containing about 1 million cells each for implants. The patient’s material is cryopreserved for further expansion and other injections. These cells are introduced in dermis by retro-injections. Improvement can be seen after the third week of implantation. This procedure is not approved in Brazil, and authors’ experience is based on their investigative studies. In this chapter, the concept, mechanism of action, and clinical applications are going to be discussed.

Keywords

Injectable soft tissues Fibroblasts and mesenchymal cells Autologous cells Adipose tissue Skin graft Dermis Implantation Soft tissue augmentation 

References

  1. Boss WK, Usal H, Fodor PB, Chernoff G. Autologous cultured fibroblasts: a protein repair system. Ann Plast Surg. 2000;44(5):536–42.PubMedCrossRefGoogle Scholar
  2. Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther. 2011;22(1):3–17.PubMedCrossRefGoogle Scholar
  3. da Silva Meirelles L, Fontes AM, Covas DT, Caplan AL. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5–6):419–27.CrossRefGoogle Scholar
  4. Davis T, Singharao SK, Wiyllie FS, et al. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p-53 dependent and p-53 independent mechanisms. J Cell Sci. 2003;116:1349.PubMedCrossRefGoogle Scholar
  5. Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, Ward CW, et al. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol. 2004;18:2502–12.PubMedCrossRefGoogle Scholar
  6. Dierickx P, Doevendans PA, Geijsen N, van Laake LW. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair. J Cardiovasc Transl Res. 2012;5(5):566–80.PubMedCrossRefGoogle Scholar
  7. Eça LP, Pinto AM, Pinho AM, Mazetti MP, Odo ME. Autologous fibroblast culture in the repair of aging skin. Dermatol Surg. 2012;38(8):180–4.PubMedGoogle Scholar
  8. Fram RY, Cree MG, Wolfe RR, Mlcak RP, Qian T, Chinkes DL, et al. Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children. Crit Care Med. 2010;38:1496–83.CrossRefGoogle Scholar
  9. Gaspar NK, Gaspar APA, Bruno AFM, Travassos Neto P. Tratamento das lipoatrofias localizadas com insulina monocomponente. An Bras Dermatol. 1984;59(3):135–6.Google Scholar
  10. Goalstone M, Carel K, Leitner JW, Draznin B. Insulin stimulates the phosphorylation and activity of farnesyltransferase via Ras-mitogen-activated protein kinase pathway. Endocrinology. 1997;138:5119–24.PubMedCrossRefGoogle Scholar
  11. Gospodarowicz D, Cheng J. Growth of myoblasts in lipoprotein-supplemented, serum-free medium: regulation of proliferation by acidic and basic fibroblast growth factor. In Vitro Cell Dev Biol. 1987;23:507–14.PubMedCrossRefGoogle Scholar
  12. Greco M, Villani G, Matzzucchelli F, et al. Marked ageing-related decline in efficiency of oxidative phosphorylation in human skin fibroblasts. FASEB J. 2003;17:1706–8.7.PubMedCrossRefGoogle Scholar
  13. Ish-Shalon D, Christoffersen CT, Vorwek P, Sacerdoti-Sierra N, Naor D, et al. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia. 1997;40(Suppl 2):S25–31.CrossRefGoogle Scholar
  14. Kim JE, Lee OS, Choi J, Son SW, Oh CH. The efficacy of stereoimage optical topometry to evaluate depressed acne scar treatment using cultured autologous fibroblast injection. Dermatol Surg. 2011;37(9):1304–13.PubMedCrossRefGoogle Scholar
  15. Lee JM, Moon KC, Han SK, Jeong SH, Kim WK. What tissue is formed after graft of adipose-derived stromal vascular fraction cells? J Craniofac Surg. 2013;24:636–9.PubMedCrossRefGoogle Scholar
  16. Lv GF, Chen B, Zhang WF, Wang YC, Cai WX, Tang CW, et al. The protective effect of intensive insulin treatment on the myocardium in severely scalded rats. Zhonghua Shaao Shang Za Zhi. 2007;23:168–71.Google Scholar
  17. Ma W, Wlaschek M, Tantcheva-Poor I, et al. Chronological ageing and photoageing of the fibroblasts and the dermal connective tissue. Clin Exp Dermatol. 2001;26:592.PubMedCrossRefGoogle Scholar
  18. Mambelli LI, Santos EJ, Frazão PJ, Chaparro MB, Kerkis A, Zoppa AL, et al. Characterization of equine adipose tissue-derived progenitor cells before and after cryopreservation. Tissue Eng Part C Methods. 2009;15(1):87–94.PubMedCrossRefGoogle Scholar
  19. Masur K, Vetter C, Hinz A, Tomas H, Henrich H, Niggemann B, et al. Dibetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation. Br J Cancer. 2011;104:345–52.PubMedCrossRefGoogle Scholar
  20. Minguell JJ, Conget P, Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res. 2000;33(8):881–7.PubMedCrossRefGoogle Scholar
  21. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood). 2001;226(6):507–20.CrossRefGoogle Scholar
  22. Montagna W, Carlisle K. Structural changes of aging human skin. J Invest Dermatol. 1979;73:47.PubMedCrossRefGoogle Scholar
  23. Montalcini RL, Hamburger V. Selective stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the embryo. J Exp Zool. 1951;116(2):321–61.CrossRefGoogle Scholar
  24. Munavalli GS, Smith S, Maslowski JM, Weiss RA. Successful treatment of depressed, distensible acne scars using autologous fibroblasts: a multi-site, prospective, double blind, placebo-controlled trial. Dermatol Surg. 2013a;39:1226–36.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Munavalli GS, Smith S, Maslowski JM, Weiss RA. Successful treatment of depressed, distensible acne scars using autologous fibroblasts: a multi-site, prospective, double blind, placebo-controlled clinical trial. Dermatol Surg. 2013b;39(8):1226–36.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Nishimura N, Reeve VE, Nishimura H, et al. Cutaneous metallothionein induction by ultraviolet B irradiation by interleukin-6 null mice. J Invest Dermatol. 2000;114:343.PubMedCrossRefGoogle Scholar
  27. Park BS, Jang KA, Sung JH, Park JS, et al. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg. 2008;34:1323–6.PubMedGoogle Scholar
  28. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Rhee SM, You HJ, Han SK. Injectable tissue-engineered soft tissue for tissue augmentation. J Korean Med Sci. 2014;29:S170–5.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Rodríguez R, García-Castro J, Trigueros C, García Arranz M, Menéndez P. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Adv Exp Med Biol. 2012;741:187–205.PubMedCrossRefGoogle Scholar
  31. Selleri S, Dieng MM, Nicoletti S, Louis I, Beausejour C, et al. Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells. Stem Cells Dev. 2013;22:1063–75.PubMedCrossRefGoogle Scholar
  32. Shuster S, Black MM, Vitie M. The influence of age and sex on skin thickness, sin collagen and density. Br J Dermatol. 1975;93:639–43.PubMedCrossRefGoogle Scholar
  33. Smith SR, Munavalli G, Weiss R, Maslowski JM, Hennegan KP, Novak JM. A multicenter, double-blind, placebo-controlled Trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles. Dermatol Surg. 2012;38(7 pt 2):1234–43.PubMedCrossRefGoogle Scholar
  34. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361(9351):45–6.PubMedCrossRefGoogle Scholar
  35. Taylor G, Lehrer MS, Jensen PL, et al. Involvement of follicular stem cells in forming not only follicol but also skin. Cell. 2000;102:451.PubMedCrossRefGoogle Scholar
  36. Tuvdendorj D, Zhang XJ, Chinkes DL, Aarsland A, Kulp GA, Jeschke MG, et al. Intensive insulin treatment increases donor site wound protein synthesis in burn patients. Surgery. 2011;149:512–8.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Varani J, Schuger L, Dame MK, et al. Reduced fibroblast interaction with intact collagen as an mechanism for depressed collagen synthesis in photodamaged skin. J Invest Dermatol. 2004;122:14.CrossRefGoogle Scholar
  38. Watson D, Keller GS, Lacombe V, et al. Autologous fibroblasts for treatmentoof facial rhytids and dermal depressions. Arch Facial Plast Surg. 1999;1:165.PubMedCrossRefGoogle Scholar
  39. Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg. 2007b;33:263–88.PubMedGoogle Scholar
  40. Weiss RA, Weiss MA, Beasley K, et al. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg. 2007a;33:263.PubMedGoogle Scholar
  41. Wong T, Mc Grath JA, Navsaria H. The hole of fibroblasts in tissue engineering and regeneration. Br J Dermatol. 2007;156:1490.CrossRefGoogle Scholar
  42. Yang SH, Park MJ, Yoon IH, Kim SY, et al. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp Mol Med. 2009;41:315–24.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Zhao Y, Wang J, Yan X, Li D, Xu J. Preliminary survival studies on autologous cultured skin fibroblasts transplantation by injection. Cell Transplant. 2008;17(7):775–83.PubMedCrossRefGoogle Scholar
  44. Zucconi E, Vieira NM, Bueno DF, Secco M, Jazedje T, Ambrosio CE, et al. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Stem Cells Dev. 2010;19(3):395–402.PubMedCrossRefGoogle Scholar
  45. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Universidade Federal Fluminense (UFF)NiteróiBrazil
  2. 2.Hospital Universitário de BrasíliaBrasíliaBrazil

Personalised recommendations